Bio Path reported $0 in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Baxter International USD 9.82B 1.87B Dec/2025
Bio Path USD 1000K 0 Sep/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026